Compare LYEL & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | SATL |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 482.3M |
| IPO Year | 2021 | N/A |
| Metric | LYEL | SATL |
|---|---|---|
| Price | $25.73 | $3.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $25.00 | $6.00 |
| AVG Volume (30 Days) | 91.2K | ★ 4.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,000.00 | N/A |
| Revenue This Year | N/A | $21.31 |
| Revenue Next Year | N/A | $84.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $1.26 |
| 52 Week High | $45.00 | $5.93 |
| Indicator | LYEL | SATL |
|---|---|---|
| Relative Strength Index (RSI) | 56.89 | 47.40 |
| Support Level | $21.27 | $2.73 |
| Resistance Level | $27.30 | $3.94 |
| Average True Range (ATR) | 2.01 | 0.28 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 84.87 | 24.23 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.